Glucotrack, Inc. Files 8-K on Material Agreement & Equity Sales
Ticker: GCTK · Form: 8-K · Filed: Sep 11, 2025 · CIK: 1506983
Sentiment: neutral
Topics: material-agreement, equity-sale, financial-statements
TL;DR
Glucotrack filed an 8-K for a material agreement and equity sales. Keep an eye on this.
AI Summary
On September 11, 2025, Glucotrack, Inc. filed an 8-K report detailing a material definitive agreement and unregistered sales of equity securities. The filing also includes financial statements and exhibits, indicating ongoing business activities and potential capital raises or transactions.
Why It Matters
This filing signals significant corporate activity for Glucotrack, Inc., potentially involving new partnerships, financing, or strategic shifts that could impact its market position and future performance.
Risk Assessment
Risk Level: medium — The filing indicates material definitive agreements and unregistered equity sales, which can introduce financial and operational risks for the company.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- September 11, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-41141 (identifier) — Commission File Number
- 98-0668934 (identifier) — IRS Employer Identification No.
- 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070 (address) — Business and Mail Address
FAQ
What is the nature of the material definitive agreement filed by Glucotrack, Inc.?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What type of equity securities were sold unregistered by Glucotrack, Inc.?
The filing mentions unregistered sales of equity securities, but the specific type and amount are not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on September 11, 2025.
What is Glucotrack, Inc.'s state of incorporation and fiscal year end?
Glucotrack, Inc. is incorporated in Delaware and its fiscal year ends on December 31.
What is the business address of Glucotrack, Inc.?
The business address of Glucotrack, Inc. is 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070.
Filing Stats: 3,373 words · 13 min read · ~11 pages · Grade level 16.2 · Accepted 2025-09-11 16:55:27
Key Financial Figures
- $20.0 million — nvestor has committed to purchase up to $20.0 million of the Company's common stock, par valu
- $0.001 — f the Company's common stock, par value $0.001 per share (the " Common Stock "), subje
- $3 — Regular Purchase Date is not less than $3.00, and shall further increase to 30,00
- $5.00 — Regular Purchase Date is not less than $5.00. The Investor's committed obligation un
- $500,000 — ingle Regular Purchase shall not exceed $500,000. Add-On Purchases Subject to the te
- $1,000,000 — nvestor's committed daily obligation of $1,000,000 (such maximum aggregate amount, the " I
Filing Documents
- form8-k.htm (8-K) — 70KB
- ex10-1.htm (EX-10.1) — 352KB
- ex10-2.htm (EX-10.2) — 124KB
- 0001493152-25-013094.txt ( ) — 814KB
- gctk-20250911.xsd (EX-101.SCH) — 3KB
- gctk-20250911_lab.xml (EX-101.LAB) — 33KB
- gctk-20250911_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 11, 2025 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer